Charge Transfer Copper Chelating Complex and Biogenically Synthesized Copper Oxide Nanoparticles Using Salvia officinalis Laves Extract in Comparative Spectrofluorimetric Estimation of Anticancer Dabrafenib

• Published in: Journal of fluorescence Vol. 34; no. 1; pp. 465 - 478
• Main Authors: Alterary, Seham S., Mostafa, Gamal A.E., Alrabiah, Haitham, Al-Alshaikh, Monirah A., El-Tohamy, Maha F.
• Format: Journal Article
• Language: English
• Published: New York Springer US 2024; Springer Nature B.V
• Subjects: Amino acids; Analytical Chemistry; Biochemistry; Biological and Medical Physics; Biomedical and Life Sciences; Biomedicine; Biophysics; Biotechnology; Cancer; Charge transfer; Chelation; Copper; Copper oxides; Fluorescence; Iron oxides; Magnesium stearate; Nanoparticles; Optical properties; Pharmaceuticals; Silicon dioxide; Spectrofluorimetry; Synthesis; System effectiveness; Titanium dioxide; Dabrafenib; Metal oxide nanoparticles; Copper charge transfer; Anti-cancer drug; Metal chelation; Salvia officinalis
• ISSN: 1053-0509; 1573-4994
• DOI: 10.1007/s10895-023-03388-9

Cancer is a broad category of disease that can affect virtually any organ or tissue in the body when abnormal cells grow uncontrollably, invade surrounding tissue, and/or spread to other organs. Dabrafenib is indicated for the treatment of adult patients with advanced non-small cell lung cancer. In the present study, two newly developed spectrofluorimetric probes for the detection of the anticancer drug Dabrafenib (DRF) in its authentic and pharmaceutical products using an ecologically synthesized copper oxide nanoparticle (CuONPs) from Salvia officinalis leaf extract and a copper chelate complex are presented. The first system is based on the influence of the particular optical properties of CuONPs on the enhancement of fluorescence detection. The second system, on the other hand, acts through the formation of a copper charge transfer complex. Various spectroscopic and microscopic studies were performed to confirm the environmentally synthesized CuONPs. The fluorescence detections in the two systems were measured at λ ex 350 and λ em of 432 nm. The results showed the linear concentration ranges for the DRF-CuONPs-SDS and DRF-Cu-SDS complexes were determined to be 1.0-500 n g mL − 1 and 1.0-200 n g mL − 1 , respectively. FI = 1.8088x + 21.418 (r = 0.9997) and FI = 2.7536x + 163.37 (r = 0.9989) were the regression equations. The lower detection and quantification limits for the aforementioned fluorescent systems were determined to be 0.4 and 0.8 n g mL − 1 and 1.0 n g mL − 1 , respectively. The results also showed that intra-day DRF assays using DRF-CuONPs-SDS and DRF-Cu(NO 3 ) 2 -SDS systems yielded 0.17% and 0.54%, respectively. However, the inter-day assay results for the above systems were 0.27% and 0.65%, respectively. The aforementioned two systems were effectively used in the study of DRF with excellent percent recoveries of 99.66 ± 0.42% and 99.42 ± 0.56%, respectively. Excipients such as magnesium stearate, titanium dioxide, red iron oxide, and silicon dioxide used in pharmaceutical formulations, as well as various common cations, amino acids, and sugars, had no effect on the detection of compound.